HIV/AIDS
Researchers' findings from India and the United States advance HIV/AIDS research
Published in Medical Letter on the CDC and FDA, July 16th, 2006
Study 1: Scientists have developed a candidate DNA/MVA HIV-1 subtype C vaccine for India.
According to scientists writing in the journal Vaccine, "Development of a vaccine against human immunodeficiency virus type-1 (HIV-1) is the mainstay for controlling the AIDS pandemic. An ideal HIV vaccine should induce neutralizing antibodies, CD4+ helper T cells, and CD8+ cytotoxic T cells. While the induction of broadly neutralizing antibodies remains a highly challenging goal, there are a number of technologies capable of inducing potent cell-mediated responses in animal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Anthrax Pathogenesis
Anthrax lethal toxin inhibits B cell proliferation and immunoglobulin production - Epidemiology
Injection drug use is strongest risk factor for hepatitis C infection in U.S. - Epidemiology
Temporal and geographic trends of rotavirus activity in U.S. are reported - Stroke
Endothelial microparticles are linked to ischemic stroke severity and outcome - Water-Borne Disease
Home-based chlorination and safe water storage reduce diarrhea in rural Uganda - Adverse Drug Reaction
Cancer patients can develop enterocolitis after antibody blockade - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
